PRC's Fosunpharma plans global outreach
This article was originally published in Scrip
Executive Summary
Shanghai Fosunpharma, the Hong Kong-listed healthcare business, is looking to step up its acquisition and investment activities both inside and outside the Peoples' Republic of China. While the pharma and medtech group has been very active in acquiring PRC-based companies, funds are now being earmarked to invest in non-Chinese companies interested in the PRC market.